You’ve Heard of CBD…
But What About CBG?
It wouldn’t be an understatement to say that CBD is everywhere these days. But did you know that CBD is just ONE of hundreds of phytocannabinoids found in the hemp plant? Today we want to shed light on the lesser known cannabinoid, Cannabigerol, or CBG, which has proven to offer quite a bit of therapeutic potential. Let’s get into it!
CBG is known as the “mother cannabinoid” because it is the first cannabinoid present once the hemp plant starts to grow. As the plant continues to mature, CBG gives rise to other primary cannabinoids in the hemp plant such as CBD and THC (< 0.3%). In The Science Behind CBD, we discuss how cannabinoids interact with our endocannabinoid system to bring our bodies back into balance, or achieve what is known as homeostasis.
Because our endocannabinoid system is essentially our body’s control center, we can help regulate hormones, mood disorders, blood sugar levels, alertness, sleep, pain, and functions associated with our immune system by supplementing with cannabinoids from organic plant sources.
With the hemp industry rapidly evolving, breeders, growers and scientists have started to focus on the therapeutic properties of specific cannabinoids such as CBG. As research continues, scientists are revealing that CBG has numerous therapeutic properties, namely anti-inflammatory properties, which can offer relief for many people. Due to the fact that the majority of the ailments we experience are associated with inflammation, CBG could be the answer that we have been waiting for. Once we can reduce inflammation, there is a good chance that overall pain levels and other unwanted symptoms will also reduce or even disappear. Moreover, CBG may help with relieving allergies, slowing fungal growth, reducing abnormal cell growth and may even aid in slowing the progression of neurodegenerative diseases such as Alzheimer’s, Huntington’s, Parkinson’s and Dementia.
The therapeutic potential of CBG shows a lot of promise and we believe this cannabinoid to be the unsung hero of the hemp plant! Interested in incorporating CBG into your daily regimen? Check out our high CBG formula.
As always, please feel free to reach out with any questions via e-mail at firstname.lastname@example.org, give us a call or just stop in any of our four locations!
Carrillo-Salinas FJ, Navarrete C, Mecha M, et al. A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis. PLoS One. 2014;9(4):e94733. Published 2014 Apr 11. doi:10.1371/journal.pone.0094733
Granja A. G., Carrillo-Salinas F., Pagani A., Gómez-Cañas M., Negri R., Navarrete C., et al. (2012). A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis. J. Neuroimmune Pharmacol. 7 1002–1016. 10.1007/s11481-012-9399-3
Navarro G., Borroto-Escuela D., Angelats E., Etayo Í., Reyes-Resina I., Pulido-Salgado M., et al. (2018a). Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia. Brain Behav. Immun. 67 139–151. 10.1016/j.bbi.2017.08.015
Vučković S, Srebro D, Vujović KS, Vučetić Č, Prostran M. Cannabinoids and Pain: New Insights From Old Molecules. Front Pharmacol. 2018;9:1259. Published 2018 Nov 13. doi:10.3389/fphar.2018.01259